High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation.

CONCLUSION: Tacrolimus-IPV could be a useful tool to identify patients with a greater risk of graft rejection and of developing a de novo DSA after liver transplantation.
PMID: 29713132 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - April 28, 2018 Category: Gastroenterology Authors: Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N Tags: World J Gastroenterol Source Type: research